Debt to EBITDA ratio Analysis of Connect Biopharma HLDG Ltd - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of CNTB
Dec-23-0.0049Very Poor Debt to EBITDA | Dec-22-0.0016Very Poor Debt to EBITDA | Growth-199.30% |
Debt to EBITDA Analysis of Connect Biopharma HLDG Ltd
| Debt to EBITDA Ratio of CNTB drastically fell by -199.30 % this year. |
| Debt to EBITDA Ratio with value of -0.0005 was highest in Year Dec-21 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.0049 was lowest in Year Dec-23 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.0049 is lower than Average Debt to EBITDA of -0.0020 in last five years. |
Other Debt to EBITDA Related Info of CNTB that may interest you.
Connect Biopharma HLDG Ltd Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| CNTB | 1.79 | 1.565 | 14.38 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Low Stability Stock | |
FY - Historical Debt to EBITDA of Connect Biopharma HLDG Ltd
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.0049 | -0.0016 | -0.0005 | -0.0008 | -0.0025 | 0 |
| Change | -199.30 % | -236.18 % | 37.65 % | 68.37 % |
FY Chart of Debt to EBITDA of Connect Biopharma HLDG Ltd
Note : All Data Generated at the End of Trading Hours (EOD Data)